Platelets significantly modify procoagulant activities in haemophilia A

Haemophilia

Volumn 17, Issue 5, 2011, Pages 743-751

  Wartiovaara Kautto, U ^a   Joutsi Korhonen, L ^a   Ilveskero, S ^a   Armstrong, E ^a   Lassila, R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Haemophilia; Platelet; Procoagulant activity; Thrombin

Indexed keywords

BLOOD CLOTTING FACTOR 8; COLLAGEN; COLLAGEN RECEPTOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN VI; LIPOCORTIN 5; PADGEM PROTEIN; PROCOAGULANT; THROMBIN; THROMBOPLASTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; HEMOPHILIA A; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SUBSTITUTION THERAPY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA;

ADOLESCENT; ADULT; ANNEXIN A5; BLOOD COAGULATION; BLOOD PLATELETS; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET-RICH PLASMA; THROMBIN; YOUNG ADULT;

EID: 80052022046     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02601.x     Document Type: Article

References (32)

1. Beeton K, De Kleijn P, Hilliard P et al. Recent developments in clinimetric instruments. Haemophilia 2006; 12: 102-7.
2. Van Dijk K, Fisher K, Van Der Bom JG, Grobbee DE., Van Den berg HM. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed. Haemophilia 2005; 11: 438-43.
3. Dargaud Y, Béguin S, Lienhart A et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005; 93: 475-80.
4. Genderen FR, Westers P, Heijnen L et al. Measuring patients' perceptions on their functional abilities: validation of the Haemophilia Activities List. Haemophilia 2006; 12: 36-46.
5. EMEA/HMP/BPWP/123835/2006. Report of expert meeting on factor VIII products and inhibitor development.
6. Escuriola Ettingshausen C, Halimeh S, Kurnik K et al. Symptomatic onset of severe haemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost 2001; 85: 218-20.
7. Di Paola J, Federici AB, Mannucci PM et al. Low platelet a2b1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 1999; 93: 3578-82.
8. Kunicki TJ, Federici AB, Salomon DR et al. An association of candidate gene haplotypes and bleeding severity in von Willebrand Disease (VWD) type 1 pedigrees. Blood 2004; 104: 2359-67.
9. Hrachovinova II, Cambien B, Hafezi-Moghadam A et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct haemostasis in a mouse model of haemophilia. Nat Med 2003; 9: 1020-5.
10. Lewis SJ, Stephens E, Florou G et al. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion. Brit J Haematol 2007; 138: 775-82.
11. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in haemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004; 2: 102-10.
12. Beltrán-Miranda CP, Khan A, Jaloma-Cruz AR, Laffan MA. Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 2005; 11: 326-34.
13. Timmons S, Hawiger J. Isolation of human platelets by albumin gradient and gel-filtration. In: Hawiger J ed. Methods in Enzymology. Salt Lake City, UT, USA: Academic Press, 1989: vol 169: 11.
14. Ilveskero S, Siljander P, Lassila R. Procoagulant activity on platelets adhered to collagen or plasma clot. Arterioscler Thromb Vasc Biol 2001; 21: 628-35.
15. Hemker HC, Wielders S, Kessels H, Béguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
16. Hemker HC, Giesen PLA, Ramjee M et al. The thrombogram: monitoring thrombin generation in platelet rich plasma. Thromb Haemost 2000; 83: 389-91.
17. Hemker HC, Giesen P, Al Dieri R et al. Calibrated automated thrombin generation measurement in clotting plasma. Patohphysiol Haemost Thromb 2003; 33: 4-15.
18. Varàdi K, Negrier C, Berntorp E et al. Monitoring the bioavailability of FEIBA with thrombin generation assay. J Thromb Haemost 2003; 1: 2374-80.
19. Vanschoonbeek K, Feijge MAH, Van Kampen RJW et al. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation on thrombogram characteristics. J Thromb Haemost 2004; 2: 476-84.
20. Hyytiäinen S, Wartiovaara-Kautto U, Ulander VM, Kaaja R, Heikinheimo M, Petäjä J. The procoagulant effects of factor V Leiden may be balanced against decreased levels of factor V and do not reflect in vivo thrombin formation in newborns. Thromb Haemost 2006; 95: 434-40.
21. Joutsi-Korhonen L, Smethurst PA, Rankin A et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 2003; 101: 4372-9.
22. Liu CY, Nossel HL, Kaplan KL. The binding of thrombin by fibrin. J Biol Chem 1979; 254: 10421-5.
23. 1 in the procoagulant response of single, collagen-adherent platelets. Thromb Haemost 1999; 81: 782-92.
24. Walsh PN. Platelet coagulant activities and haemostasis: a hypothesis. Blood 1974; 43: 597-605.
25. Yee DL. Platelets as modifiers of clinical phenotype in haemophilia. Sci World J 2006; 6: 661-8.
26. Grünewald M, Siegemund A, Grünewald A, Konegen A, Koksch M, Griesshammer M. Absence of compensatory platelet activation. Platelets 2002; 13: 451-8.
27. André P. P-selectin in haemostasis. Br J Haematol 2004; 126: 298-306.
28. Maroney SA, Haberichter SL, Friese P et al. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood 2007; 109: 1931-7.
29. Santagostino E, Mancuso M E, Tripodi A et al. Severe haemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile. J Thromb Haemost 2010; 8: 737-43.
30. Van den Berg HM, De Groot PH, Fischer K. Phenotypic heterogeneity in severe haemophilia. J Thromb Haemost 2007; 1: 151-6.
31. Franchini M, Lippi G. Factor V Leiden and haemophilia. Thromb Res 2010; 125: 119-23.
32. Hézard N, Bouaziz-Borgi L, Remy M-G, Nguyen P. Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency. Clin Chem 2006; 52: 665-70.